Anthropic announced a partnership with US AI medical platform OpenEvidence to provide AI-driven clinical decision support. The broker views this as a milestone for large models moving from lab to clinical diagnosis and treatment, and highlights two Chinese companies with valuable clinical data assets.
Northeast Securities is bullish on the AI healthcare theme, specifically recommending Jiahe Meikang and Meinian Onehealth as key data asset plays.
Free preview — more China A-share & HK research · About Us · Legal & Privacy